A Study Comparing the Effects and Safety of Dulaglutide With Insulin Glargine in Type 2 Diabetes Mellitus

NCT01648582 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

774

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: Dulaglutide
DRUG: Insulin glargine
DRUG: Metformin
DRUG: Sulfonylureas

Sponsor

Eli Lilly and Company